Echo Therapeutics Schedules First Quarter 2014 Financial Results and Regulatory and Product Development Update for Friday, May 9, 2014
[PR Newswire] – PHILADELPHIA, May 8, 2014 /PRNewswire/ — Echo Therapeutics, Inc. (ECTE), a medical device company developing its Symphony® CGM System as a non-invasive, wireless continuous glucose monitoring system, today announced that it will release more
View todays social media effects on ECTE
View the latest stocks trending across Twitter. Click to view dashboard